News
True or False: Pooled trial data showed that rheumatoid arthritis patients taking tofacitinib (Xeljanz) were less likely to ...
Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...
COMMENT: Although the drugs help me shift unhealthy weight, I was then presented with an unexpected side effect, writes ...
Wall Street cruised to the finish of its strong week on Friday, as U.S. stocks glided closer to the all-time high they set ...
Newer medications, such as Mounjaro and Wegovy, exhibit both more total weight lost and faster weight regain than older ...
In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...
Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...
(Reuters) -As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the ...
Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...
The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results